There could be big money to be made based on the final results of a study to be announced at the American Society of Clinical Oncology beginning May 31. Cancer patients, doctors and pharmaceutical companies all have a lot of stake in the next wave of experimental cancer drugs, which use the human immune system to work against the disease.
Don’t forget you can visit MyAlerts to manage your alerts at any time.